Personal information

Activities

Collapse all

Funding (7)

Lead optimization of hits identified from virtual and experimental screens of multiple industrial libraries DNDi

2019-02-22 to 2021-01-31 | Grant
National Institute of Allergy and Infectious Diseases (Bethesda, US)
URL: https://app.dimensions.ai/details/grant/grant.8383181
GRANT_NUMBER: R21AI141227
Source: Self-asserted source
Michael P Pollastri via DimensionsWizard

Curaxin-137, A New Lead for Anti-Trypanosome Drug Discovery - Resubmission - 1

2017-07-14 to 2021-06-30 | Grant
National Institute of Allergy and Infectious Diseases (Bethesda, US)
URL: https://app.dimensions.ai/details/grant/grant.6952387
GRANT_NUMBER: R01AI126311
Source: Self-asserted source
Michael P Pollastri via DimensionsWizard

Lead optimization of agents targeting multiple kinetoplastid parasites

2016-12-09 to 2019-11-30 | Grant
National Institute of Allergy and Infectious Diseases (Bethesda, US)
URL: https://app.dimensions.ai/details/grant/grant.6499425
GRANT_NUMBER: R21AI127594
Source: Self-asserted source
Michael P Pollastri via DimensionsWizard

Hit-to-lead optimization for sleeping sickness drug discovery

2016-08-19 to 2020-07-31 | Grant
National Institute of Allergy and Infectious Diseases (Bethesda, US)
URL: https://app.dimensions.ai/details/grant/grant.5503565
GRANT_NUMBER: R01AI124046
Source: Self-asserted source
Michael P Pollastri via DimensionsWizard

Hit-to-lead discovery for sleeping sickness via industry-academic partnership

2014-12-04 to 2020-11-30 | Grant
National Institute of Allergy and Infectious Diseases (Bethesda, US)
URL: https://app.dimensions.ai/details/grant/grant.3858856
GRANT_NUMBER: R01AI114685
Source: Self-asserted source
Michael P Pollastri via DimensionsWizard

Lead Optimization of Lapatinib Analogs for Human African Trypanosomiasis

2014-08-15 to 2016-07-31 | Grant
National Institute of Allergy and Infectious Diseases (Bethesda, US)
URL: https://app.dimensions.ai/details/grant/grant.3805618
GRANT_NUMBER: R56AI099476
Source: Self-asserted source
Michael P Pollastri via DimensionsWizard

Validation and development of trypanosomal phosphodiesterase inhibitors for treat

2009-04-01 to 2015-03-31 | Grant
National Institute of Allergy and Infectious Diseases (Bethesda, US)
URL: https://app.dimensions.ai/details/grant/grant.2458636
GRANT_NUMBER: R01AI082577
Source: Self-asserted source
Michael P Pollastri via DimensionsWizard

Peer review (33 reviews for 7 publications/grants)

Review activity for ACS chemical biology. (1)
Review activity for ACS infectious diseases. (8)
Review activity for ACS medicinal chemistry letters. (9)
Review activity for Chemical reviews. (1)
Review activity for Journal of chemical information and modeling. (1)
Review activity for Journal of medicinal chemistry. (12)
Review activity for Journal of organic chemistry. (1)
How many people are using ORCID?